Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
Novartis launches YouTube cancer talk show
Each Voice Counts forms part of firm’s existing advanced breast cancer initiative
Novartis is using YouTube to broadcast a new talk show about advanced breast cancer as part of its ongoing disease awareness efforts in the area.
The first episode of its Each Voice Counts talk show series features four women sharing their stories of life with the condition.
Novartis' key product in the area is Afinitor (everolimus), which gained European approval for advanced breast cancer in July, just days after US regulators passed it for the same indication.
The Each Voice Counts talk show follows the re-launch last week of Novartis' global AdvancedBreastCancerCommunity.org website.
The website is a collaboration between Novartis and Inspire, which builds and manages online support communities for patients and carers.
Advanced Breast Cancer Community offers a 'clearing house' of tailored information, covering topics such as creating a personal care plan and metastasis and recurrence.
Novartis' use of YouTube for videos in a talk show format, though unusual, is not unique, and has echoes of the Johnson & Johnson's employee video series ennTV, which debuted in April and the New Way RA talk show it began in 2009.
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Novartis back in the spotlight over Trump/Cohen links
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Germany's coronavirus infections climb but deaths remain low
- FDA grants emergency authorisation to chloroquine for COVID-19
- J&J says COVID-19 vaccine could be ready in early 2021
- New study identifies drugs that are safe to use in COVID-19 treatment
- We’re Celebrating Ten Magical Years for Ify at Lucid Group
- NICE publishes new COVID-19 management guidelines
- Servier agrees to buy Symphogen to swell its cancer pipeline
- FDA approves expanded use of BMS’ Reblozyl in blood disorders
- Key emerging trends in digital health
- What challenges still face clinical trial recruitment and retention?
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- What challenges still face clinical trial recruitment and retention?
- Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Quick links
Infographics
